NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced late Wednesday that it has priced an offering of $1.2 billion aggregate principal amount of its 2.950 percent senior notes due 2026 at the issue price of around 98.8 percent of the principal amount.

The issuance is expected to close on or about Sept. 19, and the firm said it plans to use much of the proceeds to redeem all of the outstanding $900 million aggregate principal amount of its 1.30 percent senior notes due 2017, which mature on Feb. 1, 2017. The remaining proceeds will be used for general corporate purposes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.